BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22394304)

  • 1. Androgens and breast cancer risk.
    Kenemans P; van der Mooren MJ
    Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():46-9. PubMed ID: 22394304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone and the breast.
    Shufelt CL; Braunstein GD
    Menopause Int; 2008 Sep; 14(3):117-22. PubMed ID: 18714077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.
    Bitzer J; Kenemans P; Mueck AO;
    Maturitas; 2008 Mar; 59(3):209-18. PubMed ID: 18343056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal testosterone therapy and breast cancer risk.
    Somboonporn W; Davis SR
    Maturitas; 2004 Dec; 49(4):267-75. PubMed ID: 15531122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens and breast cancer.
    Kotsopoulos J; Narod SA
    Steroids; 2012 Jan; 77(1-2):1-9. PubMed ID: 22015396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and the breast.
    von Schoultz B
    Maturitas; 2007 May; 57(1):47-9. PubMed ID: 17386984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
    Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
    Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
    Braunstein GD
    J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.
    Abdallah RT; Simon JA
    Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
    Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
    Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.